Verification register Bio, Health & Neuro
Current reading
Readiness band and full integer triple
AI-assisted assembly · derived results
Readiness band
Mature
Primary summary from verified readiness
- Confidence
- 65% · fresh
- Computed at
- 2026-09-22T00:12:02.437344+00:00
- Claimed
- 100
- Reported
- 96
- Verified
- 86
- Gap
- +14
Public ambition and stated capability
Observed practitioner reporting
Independently supported evidence
Claimed leads verified
Evidence strength Strong
Decision
What the current evidence supports
Human editorial judgment · 2026-09-22
Adopt with guardrails
- Why
- Statistically robust, clinically meaningful separation from placebo (TIS 46.5 vs 31.2, P<.001; steroid-sparing) makes it a genuine first-in-class milestone, but the boxed warning and single-trial evidence base warrant caution before over-weighting it.
- Next
- Track FDA post-marketing surveillance, REMS-equivalent safety reporting, and 12-24 month real-world outcomes before citing this as a template for JAK/TYK2-targeted rare-disease launches.
Constraints
Blockers
No named blocker is present in the current public projection.
Evidence summary
Derived counts
AI-assisted assembly
- Total
- 5
- Tier 1
- 0
- Tier 2
- 3
- Tier 3
- 2
- Supports
- 4
- Contradicts
- 1
- Context
- 0
- Latest observed
- 2026-08-28
Counts and dates only. Raw signals, private excerpts, trust records, and internal corpus material are not published here.
Publication record
Revisions
Initial public reading
- 2026-09-21 Reading moved from mature to mature.